Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH5 | P11766 | 2/20 | 0.79 |
| ▸ | XDH | P47989 | 7/20 | 0.65 |
| ▸ | RPA1 | P27694 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 3/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2667739 | 0.98 | ADH5 (0.75) | ADH5XDHRPA1ATMTP53 | |
| SCHEMBL9984638 | 0.87 | ADH5 (0.95) | ADH5XDHRPA1ATMTP53 | |
| SCHEMBL8264193 | 0.82 | XDH (0.66) | ADH5XDHRPA1ATMTP53 | |
| SCHEMBL16326388 | 0.81 | TP53 (0.58) | ADH5XDHRPA1ATMTP53 | |
| Methylbiphenyl Tetrazole SCHEMBL8171721 | 0.80 | MEN1 (0.69) | XDHALDH1A1 | |
| SCHEMBL17208850 | 0.79 | ADH5 (0.79) | ADH5XDHRPA1ATMTP53 | |
| SCHEMBL5891983 | 0.79 | ADH5 (0.79) | ADH5XDHRPA1ATMTP53 | |
| SCHEMBL23512757 | 0.79 | TP53 (0.96) | ADH5XDHRPA1ATMTP53 | |
| SCHEMBL17204982 | 0.78 | ADH5 (0.76) | ADH5XDHRPA1ATMTP53 | |
| SCHEMBL17208852 | 0.77 | ADH5 (0.75) | ADH5XDHRPA1ATMTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138303-B2 | Polymers | BASF SE (DE) | 2012-03-20 | — | — | US | disclosed |
| US-20100249349-A1 | Novel Polymers | UDC IRELAND LIMITED (IE) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249349-A1 | Novel Polymers | OCIAD2, OCIAD1, SLCO4C1 | ADH5 516/4885XDH 1669/4885RPA1 1051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.